Apptly Announces $1,000,000 Non-Brokered Private Placement

Rhea-AI Summary

Apptly Health Technologies (CSE: APPT, FSE: 4KL) plans a non-brokered private placement of up to 8,000,000 units at $0.125 per unit, for gross proceeds of up to $1,000,000. Each unit includes one common share and one warrant exercisable at $0.25 for 12 months.

Warrants may be accelerated if Apptly’s share price equals or exceeds $0.35 on the CSE for 30 consecutive trading days. Net proceeds are expected to be used primarily for general working capital. The securities will be subject to a four-month-and-one-day hold period under Canadian securities laws.

Positive

• Up to $1,000,000 in gross proceeds via non-brokered private placement
• Financing structure includes 8,000,000 warrants at $0.25, potentially adding future capital
• Company may increase the size of the offering at its discretion

Negative

• Potential dilution from issuance of up to 8,000,000 new shares, plus additional shares if warrants are exercised

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Vancouver, British Columbia--(Newsfile Corp. - August 24, 2026) - Apptly Health Technologies Corp. (CSE: APPT) (FSE: 4KL) (the "Company") is pleased to announce that it intends to complete a non-brokered private placement of up to 8,000,000 units of the Company (the "Units"), at a price of $0.125 per Unit, for aggregate gross proceeds of up to $1,000,000 (the "Offering"). The Company reserves the right to increase the size of the Offering in its sole discretion. The Offering is not subject to a minimum subscription amount.

Each Unit will consist of one common share of the Company (each, a "Share") and one common share purchase warrant of the Company (each, a "Warrant"). Each Warrant entitles the holder thereof to acquire one (1) Share at any time for a period of twelve (12) months following the closing date of the Offering (the "Closing Date") at a price of $0.25 per Share, subject to acceleration. If at any time following the Closing Date the closing price of the Shares on the Canadian Securities Exchange (the "CSE") equals or exceeds $0.35 per Share for thirty (30) consecutive trading days, the Company may accelerate the expiry date of the Warrants by issuing a news release announcing that the Warrants will expire thirty (30) days following the date of such news release. Any Warrants not exercised before the accelerated expiry date will expire and be of no further force or effect.

"Apptly has emerged as a leader in direct-pay healthcare, expanding beyond specialist visits to include outpatient surgical services-all designed to meet the growing demand for affordable, accessible care and employer-direct contracting," said Dr. Paula Muto, Founder and Interim CEO. "What we're seeing now is the emergence of an entire marketplace around direct-pay care, and companies across this space are increasingly looking to join the Apptly umbrella. This financing gives us the opportunity to accelerate that momentum, bring more high-quality physicians and services into the marketplace, and build the infrastructure needed to make direct-pay healthcare a more accessible and scalable option for employers and patients."

It is expected that the net proceeds from the Offering will be primarily used for general working capital purposes.

Any securities to be issued under the Offering will be subject to a hold period of four months and one day from the Closing Date in accordance with applicable Canadian securities laws and such other further restrictions as may apply under foreign securities laws.

The securities offered have not been registered under the U.S. Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements. This news release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any State in which such offer, solicitation or sale would be unlawful.

About Apptly Health Technologies Corp.

Apptly Health Technologies Corp. operates UberDoc, a direct-pay healthcare marketplace that connects patients directly with board-certified specialists at transparent, upfront prices, with no referral requirements, no insurance barriers, and no surprise bills. With more than 5,000 specialist physicians and clinicians across 55-plus specialties in all 50 states, the platform provides patients with faster access to care while enabling physicians to expand patient access and grow their practices. The Company was founded by Dr. Paula M. Muto, M.D.

Neither the CSE nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release

Forward-Looking Statements

This news release contains certain "forward-looking information" and "forward-looking statements" within the meaning of Canadian securities legislation as may be amended from time to time, including, without limitation, statements regarding the completion of the Offering and satisfaction of any obligations thereunder and the use of proceeds of the Offering. Forward-looking statements are statements that are not historical facts which address events, results, outcomes or developments that the Company expects to occur. Forward-looking statements are based on the beliefs, estimates and opinions of the Company's management on the date the statements are made, and they involve a number of risks and uncertainties. Certain material assumptions regarding such forward-looking statements were made, including without limitation, that there will be no material adverse change affecting the Company or its operations; that all required approvals will be obtained; that political and legal developments will be consistent with current expectations; that currency and exchange rates will be consistent with current levels; and that there will be no significant disruptions affecting the Company or its operations. Consequently, there can be no assurances that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Forward-looking statements involve significant known and unknown risks and uncertainties, which could cause actual results to differ materially from those anticipated. These risks include, but are not limited to risks associated with executing the Company's objectives and strategies, including costs and expenses, as well as those risk factors discussed in the Company's most recently filed management's discussion and analysis, available on www.sedarplus.ca. Except as required by the securities disclosure laws and regulations applicable to the Company, the Company undertakes no obligation to update these forward-looking statements if management's beliefs, estimates or opinions, or other factors, should change.

Contacts

Investor Relations / Media
Meghna Deshraj
meghna@uber-docs.com
973-369-8052
apptlyhealthtech.com

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/311339

FAQ

What are the key terms of Apptly’s (ESVNF) $1,000,000 private placement announced on August 24, 2026?

Apptly intends a non-brokered private placement of up to 8,000,000 units at $0.125 each, for gross proceeds up to $1,000,000. According to Apptly, each unit includes one common share and one 12‑month warrant exercisable at $0.25.

How many units is Apptly Health (ESVNF) offering and at what price?

Apptly plans to offer up to 8,000,000 units at a price of $0.125 per unit. According to Apptly, this structure targets aggregate gross proceeds of up to $1,000,000 and the company may increase the offering size at its discretion.

What are the warrant terms in Apptly’s (ESVNF) August 2026 private placement?

Each unit includes one warrant to buy one share at $0.25 for 12 months after closing. According to Apptly, if the share price is at least $0.35 for 30 consecutive days, it may accelerate the warrant expiry to 30 days.

How will Apptly (ESVNF) use the proceeds from the $1,000,000 private placement?

Apptly expects to use the net proceeds primarily for general working capital purposes. According to Apptly, this financing supports ongoing operations as it expands its direct-pay healthcare marketplace and related infrastructure across the United States.

Are the securities from Apptly’s (ESVNF) private placement subject to resale restrictions?

Yes, securities issued will be subject to a hold period of four months and one day from closing. According to Apptly, additional restrictions may apply under foreign securities laws, limiting when investors can resell these securities.

Can U.S. investors participate in Apptly’s (ESVNF) August 2026 private placement?

The securities have not been registered under the U.S. Securities Act of 1933 and cannot be sold in the U.S. without registration or exemption. According to Apptly, the news release does not constitute an offer or solicitation in any U.S. state.

What triggers warrant acceleration in Apptly’s (ESVNF) private placement?

Warrants may be accelerated if Apptly’s CSE share price equals or exceeds $0.35 for 30 consecutive trading days. According to Apptly, the company can then announce that warrants will expire 30 days after that news release if unexercised.